US 12006294
Therapeutic compounds
granted A61KA61K31/167A61P
Quick answer
US patent 12006294 (Therapeutic compounds) held by Regents of the University of Minnesota expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/167, A61P, A61P25/16, A61P35/00